1. Introduction {#sec1}
===============

Worldwide, already 1 billion people are overweight and more than 300 million are obese \[[@B1], [@B2]\]. Particularly, the increase in extremely overweight people was recently demonstrated (BMI ≥ 40 kg/m^2^) \[[@B1]\]. In the USA, already the prevalence of 4.8% in this group has been recorded \[[@B2]\].

Obesity is the result of a long-term positive energy balance, caused by lack of exercise combined with hypercaloric nutrition \[[@B3], [@B4]\]. An effective therapy for this multifactor health problem is the combination of multiple therapy facilities \[[@B5]\]. Also for a successful long-term effect, a multimodal treatment \[[@B5]--[@B7]\] aimed at the motivation of the obese patient for lifestyle modification is essential. Increasing physical activity and diet are important for an effective weight management \[[@B8]\].

However, a varied mixing food with the reference value of the basal metabolism is to be preferred for the effectiveness of changing the food pattern because there is often a resulting nutrient deficiency and the risk of drop-outs \[[@B7]\].

The role of activity producing a long-term effect in weight loss is well documented \[[@B9], [@B10]\]. But, there exists no consistent recommendation how much activity is enough to have the best effect. But, a higher duration of activity, such as more than 200 min/week (*P* \< 0.001), is more effective to produce greater weight loss \[[@B11]\]. This finding implicates a higher duration of activity than recommended \[[@B5], [@B12], [@B13]\].

Energy expenditure produced by physical activity and the food intake must result in a daily energy deficit of minimum 500 kcal \[[@B9]\].

Lifestyle modification in the context of more activity is the key point for successful weight management, as reported in earlier studies \[[@B11]--[@B14]\]. However, the description of the amount of activity varies and there are no reported profits for the patients with regards to quality of life. There is also lack of standardized definition about lifestyle intervention \[[@B15]--[@B19]\]. Whereas the usual kinds of lifestyle modification are mostly used for obesity close to BMI 40 kg/m² \[[@B20]\], patients with a BMI over 50 kg/m² should also start with a combined therapy in an in-patient setting \[[@B7], [@B21]\].

Obesity is linked to major depression disorders. Pagoto et al. \[[@B22]\] reported on 131 subjects with an average BMI of 43.1 that 17% were depressive, diagnosed via clinical interview (addressing DSM-IV criteria). The often discussed comorbidity of depression as a barrier to change of behaviour is approached by Schneider et al. \[[@B23]\]. So, the success is currently optimized with related behavioural-therapeutic elements \[[@B5]\] for motivation and stabilisation \[[@B24]\].

We hypothesized that an in-patient multidisciplinary nondiet weight reduction program has effectiveness for patients with a BMI \>40 kg/m² and psychological comorbidities. In detail, we assumed that patients with a BMI \>40 kg/m² can lose 5% of their initial weight with an in-patient multidisciplinary nondiet weight reduction program.

2. Method {#sec2}
=========

2.1. Participants {#sec2.1}
-----------------

198 patients with a BMI \>30 kg/m² and psychological comorbidities finished a multidisciplinary in-patient nondiet weight reduction program between February 2007 and August 2010. In consideration of the exclusion and inclusion criteria ([Table 1](#tab1){ref-type="table"}), 99 patients could be considered in a pre/postanalysis. To evaluate the effect of the program, a followup after 3, 6, and 9 month posttreatment was conducted. The in-patient treatment took 8 to 12 weeks with a structured week timetable.

2.2. Treatment {#sec2.2}
--------------

All group interventions were not constructive on each other because of the open-group situation. Activities like aqua gymnastic, walking, or a condition and coordination training (aerobic low impact and elements of resistance training using the own bodyweight), elements of relaxation, and body awareness as well as behavioural-therapeutic elements of motivation, stabilisation, and emotional regulation in group and individual settings for optimizing the success \[[@B5]\] were included. The activities were composed that the patients could integrate them in the daily routine. The behavioural therapy is taking place in group interventions and two individual calls. For the regulation of emotions, the research group have integrated a Skills-training once a week.

This extensive program is developed since January 2007 and the interventions are shown in [Table 2](#tab2){ref-type="table"}.

Objective and subjective parameters were measured pre- and posttreatment. In [Table 3](#tab3){ref-type="table"}, the parameters and their instruments of assessment are shown.

2.3. Measures {#sec2.3}
-------------

To evaluate the HRQL, the generic instrument---Short Form-36 (SF-36), a valid self-administered questionnaire \[[@B25]\]---was used. For the impact of psychological symptoms, also a self-reported questionnaire, the SCL-90 R (symptom Check list), was used \[[@B26]\]. Eating habits were assessed with a 3 factor-eating questionnaire FEV \[[@B27]\]. Body composition was measured with a bioimpedance analysis instrument (DATA INPUT Nutriguard-M). Food intake and activity were assessed with questionnaires of the validated "Schlank ohne Diät" (SOD, lean without diet) program \[[@B28]\]. For height, weight, and the waist circumference, standardized instruments were applied.

2.4. Statistical Analysis {#sec2.4}
-------------------------

For analysis, PASW statistics 18 was used. The objective parameter and dependent variable weight reduction was standardized with respect to an intended 5% weight reduction goal. Due to the non-Gaussian distribution of the data, tested with the Kolmogorow-Smirnow test, nonparametric tests (Wilcoxon test, Friedman test) were used for pre/postanalyses. The statistical significance was set at *P* \< 0.05 (two tailed). For parameter estimates, 95% confidence intervals were also computed. Binary logistic regression was used to identify predictors of achieving the weight reduction goal. Independent variables were based on previous findings: duration of the in-patient therapy \[[@B29]\], sex, age, BMI \[[@B30]\], the psychological symptoms (GSI) \[[@B23]\], and the baseline fitlevel \[[@B11], [@B13]\].

In consideration of the aim of this study, the sample was also split into participants with BMI \<40 kg/m² and BMI \>40 kg/m².

3. Results {#sec3}
==========

3.1. Sample {#sec3.1}
-----------

Data from 99 participants were obtained from medical records retrospectively.

68 (68.7%) women and 31 (31.3%) men with the mean age of 43.79 ± 12.44 (♀ 44.12 ± 12.56; ♂ 43.06 ± 12.36) were analysed. The BMI at baseline was 44.96 ± 9.93 (♀ 44.31 ± 9.61; ♂ 46.38 ± 10.61). The duration of therapy was 71.39 ± 16.2 days.

In consideration of the aim of the study to identify the effectiveness of a nondiet multidisciplinary weight reduction program, we focused on the subgroup with a BMI \>40 kg/m². Sixty-four participants had a BMI \>40 kg/m² (mean value 49.99 ± 8.74) and were included for further analysis. The mean age was 43.76 ± 12.45 years. 43 (67.2%) participants were women. The duration of in-patient therapy was 75.33 ± 14.897. Thirty of the 64 participants (46.9%) had a metabolic syndrome.

The mean load of psychological symptoms at baseline was 0.95 ± 0.65 and the subjective fitlevel was 21.83 ± 15.57. Objective parameters like body fat were at baseline 47.01 ± 7.01% and the waist circumference 147.18 ± 20.36 cm ([Table 4](#tab4){ref-type="table"}).

With the exception of triglycerides, LDL-cholesterol, and alexithymia from TAS 26, differences of all other measured parameters (*t*1 versus *t*2) were significant (*P* \< 0.05) ([Table 5](#tab5){ref-type="table"}).

The relative weight reduction of the BMI \>40 kg/m² subgroup was *∅* − 6.9 ± 3.9%. The standardized weight (5% weight reduction goal) for both subgroups is shown in [Figure 1](#fig1){ref-type="fig"}. Weight reduction over time was significant for both groups (*P* \< 0.001) with a significant group difference (*z* = −2.606; *P* = 0.009) at posttreatment. On average, both groups achieved the 5% weight goal after intervention, patients with a BMI \>40 kg/m² already at week eight. 42 of 64 (65.6%) patients with BMI \>40 kg/m² achieved the 5% weight reduction goal.

The relative weight reduction and changes in the somatoform dimension of the SCL-90 R, the dimension body pain of the SF-36, % body fat, and waist circumference were significant (Spearman correlation *P* \< 0.05; [Table 6](#tab6){ref-type="table"}).

We conducted a binary logistic regression analysis including also the patients with BMI \<40 kg/m² (total *n* = 79) regarding the achievement of the weekly weight reduction goal of a loss of 0.5 kg in average per week \[[@B28]\] to test whether patients with BMI \>40 kg/m² and patients with BMI \<40 kg/m² differed significantly in treatment outcomes. Predictors were participant, sex, incidence of the metabolic syndrome, duration of the in-patient therapy, BMI, waist circumference, and subjective activity level at baseline. Selected variables were significant in correlation with weight reduction (*P* \< 0.05). The psychological symptoms (GSI) were included in the model as a control variable (*r* = −0.19).

The chi-square test of the full model with all seven predictors was significant (*n* = 79, *χ*^2^ = 25.25, df = 7, *P* = 0.001). Model-based classifications (cut-off of 0.5) were correct in 55% of the cases for goal not attained and in 94.9% of cases for goal attained. The overall rate of correct classifications was 84.8%. Nagelkerkes *R*², as the equivalent for the proportion of the variance of the criterion explained by the predictors, was 40.9%. The Hosmer-Lemeshow test was not significant (*P* = 0.763).

Duration of an in-patient therapy (*P* = 0.007) and the BMI at baseline (*P* = 0.01) were significant predictors to attain the weight reduction goal, and a trend for the fitlevel at baseline (*P* = 0.089) was identified ([Table 7](#tab7){ref-type="table"}). The odds ratio of the duration of in-patient therapy and the fitlevel at baseline (OR \< 1) demonstrated that a higher subjective estimate of activity and also a longer hospital stay were associated with a lower probability of achieving the weight reduction goal.

Long-term outcomes (1-year followup) were available for only 23 patients, 17 (73.9%) of which had a baseline BMI \>40 kg/m². Twelve (70.6%) of these 17 patients achieved and maintained a weight reduction goal of 5--10% of their initial weight. There was a little difference between participants who make a regular use of the 3 monthly checks (*n* = 13) including also a psychological interview beside the measures of the objective and subjective parameters, to them, who came irregular to the check (*n* = 10).

4. Discussion {#sec4}
=============

The aim of the study was to demonstrate the achievement of weight reduction in the subgroup BMI \>40 kg/m² with psychological comorbidities with a multimodal nondiet in-patient weight reduction program.

The most interesting finding of the presented study was a significant weight loss over time (*P* \< 0.001) with a group difference to BMI \<40 kg/m² (*P* \< 0.05). While there were significant changes in most of the subjective and objective parameters, there were only a few psychological parameters in the subgroup BMI \>40 kg/m² correlated with weight reduction (somatoform dimension of the SCL-90 R; *r* = −0.316 and the subscale pain of SF-36; *r* = 0.441). Findings of this study in this heterogenic field of obese patients with the psychological comorbidity are consistent with past studies \[[@B22], [@B31], [@B32]\]. Psychological comorbidities were associated with less weight loss as reported by Pagoto et al. \[[@B22]\]. Whereas 16% of patients with major depression achieved a weight reduction goal of ≥7%, 38% of the nondepressed patients did it \[[@B22]\]. Comparable to Carroll et al. \[[@B31]\] improvements in cholesterol, waist circumference, and % body fat (*P* \< 0.05) as parameters of the metabolic syndrome were demonstrated. Also there was no relevant correlations between weight reduction and psychological variables reported \[[@B31]\]. Equivalent to De Zwaan et al., analysis had identified no relationship between a higher BMI and mental health \[[@B32]\]. So, patients with a BMI \>40 kg/m² had no significant group difference to a lower BMI in respect of the general symptomatic index (*F* = 0.63; *P* = 0.803). Also weight reduction was not related to PCS (*r* = 0.172) and MCS (*r* = 0.094) of the SF-36.

The relative weight reduction was higher (mean value −6.9 ± 3.9%) than in the group BMI \<40 kg/m² (mean value −4.9 ± 2.4%) \[[@B33]\]. Goodpaster et al. \[[@B33]\] demonstrated equivalent results of weight loss at patients with BMI \>40 kg/m² compared with lower BMI (10.9% versus 7% at 12 months). But, there was a high variability in both groups at the presented study. While the goal of the 0.5 kg each week \[[@B28]\] was achieved by 52 participants (81.3%), 42 of the 64 (65.6%) participants in this group obtained also the successful weight loss, defined as ≥5% from initial weight at 1-year followup \[[@B5], [@B13]\]. This value is evident for reducing the risk of cardiovascular diseases \[[@B34]--[@B36]\]. As already above-mentioned parameters of the metabolic syndrome that decreased significantly (*P* \< 0.05), there were also positive effects without weight reduction \[[@B35]\]. Body composition is one of the most interesting parameters demonstrating the improvement of risk profile. Improvements could be shown independent of weight reduction \[[@B9]\]. Waist circumference is more closely correlated with visceral obesity than the total body fat mass \[[@B36]\], but analysis demonstrated significant changes in both, waist circumference and body fat (*P* = 0.001). Similar to our findings, Galani and Schneider reported a significant decrease of body weight (*P* \< 0.0001), total cholesterol (*P* = 0.027), and waist circumference after lifestyle interventions \[[@B36]\]. So, the focus must be also on evaluation of body composition and blood markers for the metabolic syndrome to identify the benefits of a lifestyle intervention.

We found that a higher duration of in-patient therapy is not significantly correlated with weight reduction (*r* = 0.153). This finding was different to the study of Beutel et al. \[[@B37]\]. In their equivalent study, a significant correlation of weight loss with a longer in-patient treatment (*r* = 0.4) was demonstrated \[[@B37]\]. In our research, the included participants demonstrated that the 5% weight reduction goal could be achieved at week eight.

These findings were also defined at the binary logistic regression analysis. The odds ratio of the in-patient stay was 0.925 and consequentially the odds to achieve the weight reduction goal decrease with a longer in-patient therapy. Longer stays in hospital were reported to correlate with a higher load of psychological comorbidity. So, it could be expected that participants with a higher load of psychological symptoms need a longer in-patient therapy. Also interesting was the subjective estimation of the activity. Findings presented an odds ratio of 0,963 and therefore an estimation of a higher subjective fitlevel decreases the odds of obtaining the weight reduction goal. These data implicated that the self-estimation often differs from the reality.

The dependent variable of weight reduction of the binary logistic regression model was the reference value of 0.5 kg each week \[[@B28]\]. This goal of 0.5 kg weight reduction was more easily achieved for higher obese individuals. At present, there exists only a relative weight reduction reference value for long-term maintenance. So, it will be more important to find cutoff points of relative weight reduction for an in-patient therapy.

Further investigation is necessary to understand and to identify the factors which will demonstrate the effectiveness of a successful long-term weight loss of a nondiet program for participants with a BMI \> 40 kg/m². Information of the drop-outs why they do not visit the out-patient followup care should be included.

Future studies should have a control group for comparison of the progression of the increasing problem of obesity. Standardized measures and also the inclusion of objective parameters, particularly of activities to check the self-estimation of fitness against reality, would be involved.

Findings of this study demonstrated that the primary outcome should not be only the weight reduction but rather the benefits of lifestyle modification \[[@B9]\] and their increasing quality of life. Also the emotional regulation of food intake, because this is often the problem for long-term behaviour modification, must be included.

This study was supported by Psychosomatisches Zentrum Waldviertel (PSZW) Eggenburg and Eggenburg Institute for Complex Systems, Health and Neuroscience (EICoN).
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###### 

Inclusion and exclusion criteria of the study.

  Exclusion                                                                                                                                                                                 Inclusion
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------
  \(i\) Bulimia nervosa                                                                                                                                                                     \(i\) Adults with a BMI ≥ 30 kg/m² and psychological comorbidities classified to ICD-10 criteria
  \(ii\) Serious personality disorder                                                                                                                                                       \(ii\) Sufficient mobility for participation on activities and
  \(iii\) Schizophrenia                                                                                                                                                                     \(iii\) Cooperativeness for all parts of the program
  \(iv\) Conduct disorders                                                                                                                                                                  
  \(v\) Serious reduction of intelligence                                                                                                                                                   
  \(vi\) Patients after a myocardial infarct (MCI) and heart insufficiency (NYHA III/IV)                                                                                                    
  \(vii\) The existence of diabetes mellitus type I                                                                                                                                         
  \(viii\) Renal insufficiency                                                                                                                                                              
  \(ix\) Serious COPD or asthma bronchial                                                                                                                                                   
  \(x\) Serious hormonal disorders                                                                                                                                                          
  \(xi\) Tumours                                                                                                                                                                            
  \(xii\) Lactation or pregnancy                                                                                                                                                            
  \(xiii\) Attendance on another study or weight loss program at the same time                                                                                                              
  \(xiiii\) Patients with a regularly higher dosed medication known to affect appetite and/or weight like corticosteroid, SHD-hormones, or diuretics which are taken in the last 3 months   

###### 

Weekly timetable of interventions of the "schwerelos" program.

  ----------------------------------------------- ----------------------- -------------
  Medical science:\                               Medical visits          2x á 90 min
   (i) somatic comorbidities and complications\                           
   (ii) medication                                                        

  Surgery hour                                    1x á 60 min             

  Psychiatric consultation                        1x á 60 min             

  Psychology:\                                    Individual therapy      2x á 50 min
   (i) behaviour\                                                         
   (ii) emotion\                                                          
   (iii) cognition\                                                       
   (iv) motivation                                                        

  Group intervention                              2x á 60 min             

  Skills and social competence training           each 2x á 60 min        

  Self-image                                      1x á 60 min             

  Relaxation                                      1x á 60 min             

  Nutrition:\                                     Nutrition information   2x á 60 min
   (i) balanced meal (food guide pyramid)                                 

   (ii) food pattern, typus of food intake        Individual counseling   1x á 60 min

  Activity:\                                      Aqua-gymnastic          2x á 30 min
   (i) cardiotraining\                                                    
   (ii) strengthendurance                                                 

  Music-gymnastic/low-impact                      2x á 30 min             

  Walking                                         2x á 30 min             
  ----------------------------------------------- ----------------------- -------------

###### 

Parameters and methods of assessment.

  Parameter                                Method
  ---------------------------------------- ---------------------
  Anthropometric:                          
   Height, weight ---\> BMI                Scale, chain, kg/m²
   Waist circumference                     
   Body composition                        BIA
  Blood Serum:                             
   Cholesterol/LDL-C                       Haemogram
   Triglyceride                            
  Nutrition:                               
   Nutrition behaviour                     FEV
   Food intake                             Recall (SOD)
  Psychological Symptoms and Well-Being:   
   Depression/psychological symptoms       SCL-90-R
   Health related quality of life (HRQL)   SF-36
  Activity:                                
   Fitlevel                                SOD

###### 

Descriptive statistic of patients with BMI *≶*40 kg/m².

                                       *N*   Mean value   S.E.    *N*   Mean value   S.E.    *N*   Mean value   S.E.
  ------------------------------------ ----- ------------ ------- ----- ------------ ------- ----- ------------ -------
  Age (years)                          99    43,79        12,44   64    43,76        12,45   35    43,83        12,61
  Weight (kg)                          99    129,60       35,49   64    143,29       35,69   35    104,56       16,54
  BMI (kg/m²)                          99    44,96        9,93    64    49,99        8,75    35    35,76        2,75
  Waist circumference (cm)             98    136,53       22,75   63    147,18       20,36   35    117,37       11,52
  Body fat (%)                         98    44,72        7,28    63    47,01        7,01    35    40,61        5,86
  GSI                                  97    ,9432        ,62     64    ,95          ,65     33    ,9212        ,56
  Fitlevel                             80    24,74        15,67   54    21,83        15,58   26    30,77        14,35
  Weight reduction in %                93    −6,01        3,38    59    −6,63        3,69    34    −4,95        2,47
  Duration in-patient therapy (days)   99    71,39        16,20   64    75,33        14,9    35    64,20        16,21

###### 

Descriptive statistics of the subgroup BMI \>40 kg/m².

  Descriptive statistic *n* = 64           *t*1   *t*2                                                             
  ---------------------------------------- ------ ------- ------- -------- ------- ---- ------ ------ ------------ -------
  Psychological parameters                                                                                         
                                                                                                                   
  BDI                                      58     0       38      19,01    9,55    52   0      34     9,97\*\*     7,56
  SCL90R somatoform dimension              64     1       36      12,20    9,33    61   0      35     8,28\*\*     8,56
  SCL90R depressive dimension              64     0       47      16,12    11,48   61   0      41     8,7\*\*      8,76
  SCL90R general symptomatic index (GSI)   64     0,02    3,39    0,95     0,65    61   0      2,89   0,58\*\*     0,52
  IIPD                                     64     0,41    2,8     1,71     0,47    61   0,09   2,64   1,40\*\*     0,55
  TAS26                                    37     25      63      46,09    9,99    35   30     69     45,97        10,03
                                                                                                                   
  Eating habits                                                                                                    
                                                                                                                   
  FEV_cognitive restraint                  33     1       15      7,18     3,74    31   1      20     12,16\*\*    5,33
  FEV_uncontrolled eating                  33     1       16      10,24    3,75    31   1      15     6,55\*\*     3,86
  Fitlevel                                 54     0       58      21,83    15,58   50   8      99     65,28\*\*    16,63
                                                                                                                   
  Health related quality of life                                                                                   
                                                                                                                   
  SF36 physical functioning                37     5       95      46,38    23,98   35   0      100    62,86\*\*    26,13
  SF36 physical role limitation            37     0       100     29,28    36,57   35   0      100    56,91\*\*    43,04
  SF36 pain                                37     0       100     48,34    28,12   35   12     100    62,59\*\*    27,48
  SF36 general health                      37     19      92      50,28    17,11   35   25     97     63,69\*\*    19,09
  SF36 vitality                            37     5       80      34,32    17,13   35   15     100    58,29\*\*    19,81
  SF36 social functioning                  37     0       100     54,05    27,01   35   12,5   100    68,93\*\*    27,35
  SF36 emotional role limitation           37     0       100     39,64    39,16   35   0      100    66,67\*\*    45,01
  SF36 mental health                       37     12      100     55,24    19,09   35   24     100    66,86\*\*    19,00
  SF36 physical summary score (PCS)        37     15      52      35,72    10,00   35   15,2   56,3   42,51\*\*    10,56
  SF36 mental summary score (MCS)          37     20      61,7    39,68    11,53   35   22,8   63,1   47,51\*\*    11,60
                                                                                                                   
  Anthropometric parameters                                                                                        
                                                                                                                   
  Weight (kg)                              64     104,6   322,5   143,29   35,68   64   96     299    133,13\*\*   32,01
  BMI                                      64     38      84      49,99    8,74    61   35,1   77,8   46,43\*\*    8,01
  Waist circumference (cm)                 63     115     230     147,18   20,36   64   112    220    139,8\*\*    19,47
  \% Body fat                              63     28,7    60      47,01    7,01    58   23,2   58,1   44,39\*\*    7,59
                                                                                                                   
  Blood parameters                                                                                                 
                                                                                                                   
  Cholesterol (mg/dL)                      58     126     305     189,71   38,72   57   118    267    179,84\*     34,81
  LDL-cholesterol (mg/dL)                  54     48      201     110,41   33,54   56   40     182    106,36       32,35
  Triglycerides (mg/dL)                    58     75      466     166,12   76,62   57   65     329    159,6        57,32

*t*1: pre treatment, *t*2: posttreatment.

\*Correlation is significant at *P* \< 0,05 (two-tailed).

\*\*Correlation is significant at *P* \< 0,01 (two-tailed).

###### 

Spearman correlation matrix of weight reduction and selected variables at BMI \>40 kg/m².

  Spearman-Rho       Duration of in-patient therapy   General Symptomatic Index (GSI)   Somatoform dimension SCL-90 R   Depressive dimension SCL-90 R   Physical summary score SF36 (PCS)   Mental summary score SF 36 (MCS)   Age    Waist   \% body fat   Fit-level   
  ------------------ -------------------------------- --------------------------------- ------------------------------- ------------------------------- ----------------------------------- ---------------------------------- ------ ------- ------------- ----------- ------
  Weight reduction   *r*                              −,153                             ,144                            ,316\*                          ,170                                ,172                               ,094   −,083   ,612\*\*      ,855\*\*    ,160
  *N*                64                               61                                61                              61                              35                                  35                                 64     63      58            50          

\*\*Correlation is significant at *P* \< 0,01 (two-tailed).

\*Correlation is significant at *P* \< 0,05 (two-tailed).

###### 

Variables in the logistic regression model.

                                 *B*    Wald   Sig.   OR      95% C.I. for OR   
  ------------------------------ ------ ------ ------ ------- ----------------- -------
  *Step  *1^a^                                                                  
   Sex (1)                       ,84    1,06   ,304   2,309   ,47               11,38
   MTS (1)                       ,03    ,00    ,975   1,026   ,21               5,09
   Age                           ,00    ,01    ,944   1,002   ,94               1,07
   Duration in-patient therapy   −,08   7,35   ,007   ,925    ,87               ,98
   BMI                           ,13    6,64   ,010   1,143   1,03              1,27
   Fitlevel                      −,04   2,89   ,089   ,963    ,92               1,01
   GSI                           ,24    ,16    ,686   1,277   ,39               4,18
   Constant                      1,68   ,33    ,564   5,386                     

^a^Variables entered on step 1: sex, metabolic syndrome (MTS), age, duration of in-patient therapy, BMI, fitlevel and general symptomatic index (GSI) at baseline.
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